Price RB - Search Results

1

Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

Mathew SJ, Price RB, Mao X, Smith EL, Coplan JD, Charney DS, Shungu DC. Mathew SJ, et al. Among authors: price rb. Biol Psychiatry. 2008 May 1;63(9):891-8. doi: 10.1016/j.biopsych.2007.09.012. Epub 2007 Oct 29. Biol Psychiatry. 2008. PMID: 18028881 Free PMC article. Clinical Trial.

2

Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.

Mathew SJ, Price RB, Charney DS. Mathew SJ, et al. Among authors: price rb. Am J Med Genet C Semin Med Genet. 2008 May 15;148C(2):89-98. doi: 10.1002/ajmg.c.30172. Am J Med Genet C Semin Med Genet. 2008. PMID: 18412102 Review.

3

Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.

Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ. Price RB, et al. Biol Psychiatry. 2009 May 1;65(9):792-800. doi: 10.1016/j.biopsych.2008.10.025. Epub 2008 Dec 5. Biol Psychiatry. 2009. PMID: 19058788 Free PMC article.

4

A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder.

Mathew SJ, Price RB, Shungu DC, Mao X, Smith EL, Amiel JM, Coplan JD. Mathew SJ, et al. Among authors: price rb. J Psychopharmacol. 2010 Aug;24(8):1175-81. doi: 10.1177/0269881108101796. Epub 2009 Feb 9. J Psychopharmacol. 2010. PMID: 19204062

5

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

Price RB, Nock MK, Charney DS, Mathew SJ. Price RB, et al. Biol Psychiatry. 2009 Sep 1;66(5):522-6. doi: 10.1016/j.biopsych.2009.04.029. Epub 2009 Jul 9. Biol Psychiatry. 2009. PMID: 19545857 Free PMC article. Clinical Trial.

6

The relation of worry to prefrontal cortex volume in older adults with and without generalized anxiety disorder.

Mohlman J, Price RB, Eldreth DA, Chazin D, Glover DM, Kates WR. Mohlman J, et al. Among authors: price rb. Psychiatry Res. 2009 Aug 30;173(2):121-7. doi: 10.1016/j.pscychresns.2008.09.010. Epub 2009 Jun 25. Psychiatry Res. 2009. PMID: 19559575 Free PMC article.

7

Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.

Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, Soleimani L, Charney DS, Foulkes AL, Mathew SJ. Price RB, et al. Depress Anxiety. 2014 Apr;31(4):335-43. doi: 10.1002/da.22253. Epub 2014 Mar 25. Depress Anxiety. 2014. PMID: 24668760 Free PMC article. Clinical Trial.

8

Does ketamine have anti-suicidal properties? Current status and future directions.

Price RB, Mathew SJ. Price RB, et al. CNS Drugs. 2015 Mar;29(3):181-8. doi: 10.1007/s40263-015-0232-4. CNS Drugs. 2015. PMID: 25715884 Free PMC article. Review.

9

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.

Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS. Murrough JW, et al. Among authors: price rb. Psychol Med. 2015 Dec;45(16):3571-80. doi: 10.1017/S0033291715001506. Epub 2015 Aug 12. Psychol Med. 2015. PMID: 26266877 Clinical Trial.

10

Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring Change.

Mathew SJ, Price RB. Mathew SJ, et al. Among authors: price rb. Am J Psychiatry. 2020 Feb 1;177(2):107-109. doi: 10.1176/appi.ajp.2019.19121242. Am J Psychiatry. 2020. PMID: 32008392 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page